Coastal Investment Advisors, Inc. Invitae Corp Transaction History

Coastal Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$28.43 - $44.67 $505,997 - $795,036	-17,798 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$11.71 - $30.29 $208,414 - $539,101	17,798 New	17,798 $539,000
Q1 2020 Apr 23, 2020	SELL	$7.64 - $27.5 $397,493 - $1.43 Million	-52,028 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$15.02 - $20.57 $3,980 - $5,451	265 Added 0.51%	52,028 $1.04 Million
Q3 2019 Oct 18, 2019	SELL	$18.85 - $27.5 $32,799 - $47,850	-1,740 Reduced 3.25%	51,763 $1.01 Million
Q2 2019 Aug 01, 2019	BUY	$17.37 - $26.27 $66,353 - $100,351	3,820 Added 7.69%	53,503 $1.27 Million
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $529,123 - $1.28 Million	49,683 New	49,683 $1.17 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.